<?xml version="1.0" encoding="UTF-8"?>
<ref id="B157">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Richardson</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Griffin</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Tucker</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Oechsle</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Phelan</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2020</year>). 
  <article-title>Baricitinib as potential treatment for 2019-nCoV acute respiratory disease</article-title>. 
  <source>Lancet</source>
  <volume>395</volume>, 
  <fpage>e30</fpage>â€“
  <lpage>e31</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30304-4</pub-id>
  <?supplied-pmid 32032529?>
  <pub-id pub-id-type="pmid">32032529</pub-id>
 </mixed-citation>
</ref>
